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Background
HIV-1 encodes an essential regulatory protein, Tat which
orchestrates viral gene expression from the HIV-1 promo-
ter. Tat activity depends on Tat hijacking the nuclear
transport system to gain access to the transcriptional
machinery. The sole import factor identified for Tat to
date, Importin b, directly interacts with Tat-NLS to med-
iate its active nuclear import. While Tat localises in the
nucleoli & nucleoplasm of transformed cells, in HIV-1
infected primary T-cells, Tat accumulates at the plasma
membrane, where it is secreted. The different subcellular
accumulation of Tat could be due to selective enhance-
ment of the nuclear import machinery in transformed
cells or alternatively, an increase in Tat nuclear export or
its specific cytosolic retention in primary T cells. Of note,
Tat does not contain a classical NES and its nuclear export
remains to be established. Here, we characterise the bidir-
ectional transport receptor, Importin 13 (IPO13) as a
novel transport receptor mediating the nucleo-cytoplasmic
shuttling of Tat.
Methods
Co-localisation studies were performed using immuno-
fluorescence and confocal microscopy, followed by decon-
volution. For protein interaction studies, in vitro GST
pulldowns were employed using recombinant GST-YFP-
Tat and corresponding mutants with 6xhis-IPO13. In vitro
nuclear transport assays were performed using digitonin
permeabilised HeLa cells. Tat activity was monitored
using HeLa-LTR-Luc reporter cells. SiRNA knockdown of
IPO13 was validated by Western blot.
Results
GST pulldowns demonstrated that Tat interacts directly
with IPO13 via its NLS, as well as via additional NLS
independent binding sites. In vitro transport assays
revealed IPO13 as a novel import factor for HIV-1 Tat
and identified residues 49R50K51K within Tat-NLS as
essential for import by IPO13. Of note, IPO13-mediated
Tat nuclear import unusually resulted in Tat nucleoplas-
mic distribution with weak nucleolar staining, while
IPO13 import of the Tat-NLS alone resulted in a typical
strong nucleolar accumulation. Importantly, IPO13
could mediate the active, CRM-1 independent nuclear
export of Tat, but not Tat-NLS alone, via the Nuclear
Pore Complexes. Collectively, these results suggest that
the Tat-NLS is sufficient for interaction with IPO13 and
nuclear import, but Tat nuclear export by IPO13
requires additional domains. Interestingly, overexpres-
sion of IPO13 induced Tat redistribution to the cyto-
plasm in vivo. Finally, siRNA mediated knockdown of
IPO13 in HeLa-LTR-Luc reporter cells inhibited Tat
transactivation by 60%, compared to non-target siRNA
controls, highlighting the functional significance of
IPO13 for Tat activity.
Conclusions
We have identified IPO13 as an essential new transport
factor for Tat and provided the first evidence of Tat
nucleo-cytoplasmic shuttling, which could have func-
tional implications for Tat cytoplasmic activities and its
secretion by infected cells.
Published: 19 September 2013
doi:10.1186/1742-4690-10-S1-P102
Cite this article as: Woods et al.: Novel evidence for the
nucleocytoplasmic shuttling of HIV-1 Tat by Importin13. Retrovirology
2013 10(Suppl 1):P102.
UCD-Centre for Research in Infectious Diseases, SMMS, University College
Dublin, Dublin, Ireland
Woods et al. Retrovirology 2013, 10(Suppl 1):P102
http://www.retrovirology.com/content/10/S1/P102
© 2013 Woods et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
